VVT MedVVTMF 6 EBITDA Margin % is -30,714.29% as of Sep. 2025. GuruFocus rates VVTMF with a GF Score™ of 6/100. The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, VVT Med ranks worse than 95.46% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. VVT Med's EBITDA for the
three
months ended in Sep. 2025 was $-2.15 Mil. VVT Med's Revenue for the
three
months ended in Sep. 2025 was $0.01 Mil. Therefore, VVT Med's EBITDA margin for the quarter that ended in Sep. 2025 was -30,714.29%.
VVT Med (OTCPK:VVTMF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
VVT Med EBITDA Margin % Related Terms
VVT Med EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for VVT Med's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VVTMF vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, VVT Med's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VVT Med EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, VVT Med's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where VVT Med's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VVT Med (VVTMF) has a EBITDA Margin % of -30,714.29% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on VVT Med and its competitors. According to the industry distribution chart, VVT Med ranks #778 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 95.5%.
Is VVT Med's EBITDA Margin % too high?
VVT Med's current EBITDA Margin % is -30,714.29%. Based on the distribution chart, VVT Med ranks #778 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, VVT Med has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does VVT Med's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, VVT Med ranks #778 out of 815 companies for EBITDA Margin %. This places VVT Med in the lower half of its industry. The industry median EBITDA Margin % is 7.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.47, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on VVT Med and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. VVT Med's current EBITDA Margin % is -30,714.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VVT Med stock overvalued right now?
VVT Med (VVTMF) has a current EBITDA Margin % of -30,714.29%. The current EBITDA Margin % is -30,714.29%. VVT Med's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For VVT Med (VVTMF), the current EBITDA Margin % is -30,714.29% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
VVT Med Inc is a medical device company, focused on developing and commercializing a range of minimally invasive technologies for treating varicose veins. VVT's research and development activities are based in Israel. The company proudly boasts three products within its portfolio that have achieved commercial production status and are currently available in the market. These products have undergone meticulous design processes, obtaining regulatory approvals across multiple countries.
6GF Score
Get the complete analysis for VVTMF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VVTMF has been successfully added to your 
